The identification of the novel causative genes in embryonal rhabdomyosarcoma and the elucidation of the molecular mechanism
The identification of the novel causative genes in embryonal rhabdomyosarcoma and the elucidation of the molecular mechanism
批准号:
18590378
负责人:
KAKAZU Naoki
金额:
$2.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rhabdomyosarcoma is the most common soft tissue tumor seen in children and young adults. Rhabdomyosarcoma can be classified into two major histological subtypes, alveolar and embryonal. In the alveolar subtype, two recurrent chromosomal translocations, t(2;13)(q35;q14) and its variant t(1;13)(p36;q14), have been identified as the specific cytogenetic abnormalities. These translocations create the PAX3-FOXO1 and PAX7-F0X01 fusion genes, respectively. In the embryonal subtype, however, no recurrent chromosomal abnormalities have been identified.In this study, we analyzed the complex chromosomal translocation t(2;8;12) in one case with embryonal rhabdomyosarcoma by means of spectral karyotyping (SKY) and identified a novel translocation involving chromosome band 2q35, which is the locus of PAX3 gene. Furthermore, we identified the novel PAX3 rearrangement using fluorescence in situ hybridization (FISH) analysis. To identify the partner gene located on the 8q breakpoint in this case, we performed sequential FISH analyses using bacterial artificial chromosome (BAC) probes located on 8q. The BAC clones (RP11 series) were selected according to the University of California Santa Cruz (UCSC) Genome Browser (http://genome. ucsc. edu). The results suggested that TIF2 gene (8p11) spanned the 8q breakpoint of complex t(2;8;12). Furthermore, FISH analysis showed the PAX3-TIF2 fusion in tumor cells. Unfortunately, we could not determine the molecular structure of the PAX3-TIF2 fusion gene.To identify others translocations involving the TIF2 gene in rhabdomyosarcoma, we analyzed rhabdomyosarcoma cell lines (Rh2, RD, HKBm, RM2, and Rh30) using FISH. However, no translocations involving the TIF2 gene were detected.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Multicolor banding technique, spectral color banding (SCAN) : new development and applications
多色条带技术,光谱色带(SCAN):新发展和应用
DOI:
--
发表时间:
2006
期刊:
Cytogenet Genome Res 114
影响因子:
--
作者:
[Kakazu N, et al.]
通讯作者:
et al.
DOI:
10.1073/pnas.0610732104
发表时间:
2007-01-30
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
[Kotani, Ai, Kakazu, Naoki, Honjo, Tasuku]
通讯作者:
Honjo, Tasuku
Clinical features of hypereosinophilic syndrome (HES): FIP1L1-PDGFRA fusion gene positive-HES is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid
嗜酸性粒细胞增多综合征 (HES) 的临床特征:FIP1L1-PDGFRA 融合基因阳性 - HES 是一种独特的临床实体,具有骨髓增殖特征且对皮质类固醇反应不佳
DOI:
--
发表时间:
2007
期刊:
Int J Hematol 85
影响因子:
--
作者:
[Miyazawa K, Kakazu N, et. al.]
通讯作者:
et. al.
Multicolor banding technique, spectral color banding (SCAN) : new development and applications.
多色条带技术,光谱色带(SCAN):新开发和应用。
DOI:
--
发表时间:
2006
期刊:
Cytogenet Genome Res 114
影响因子:
--
作者:
[Kakazu N, et al., Kakazu N]
通讯作者:
Kakazu N
Clinical features of hypereosinophilic syndrome (HES) : FIP1L1-PDGFRA fiision gene positive-HES is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid
嗜酸性粒细胞增多症 (HES) 的临床特征:FIP1L1-PDGFRA 分裂基因阳性 - HES 是一种独特的临床实体,具有骨髓增殖特征且对皮质类固醇反应不佳
DOI:
--
发表时间:
2007
期刊:
Int J Hematol 85
影响因子:
--
作者:
[Miyazawa K, et al.]
通讯作者:
et al.
共 8 条
Identification of novel causative genes in mesothelioma and the elucidation of the carcinogenic mechanism
-
批准号:23590464
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:KAKAZU Naoki
-
依托单位:
Identification of a novel chimera gene not involving PAX family gene in rhabdomyosarcoma cell lines
-
批准号:20590365
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:KAKAZU Naoki
-
依托单位:
Development of automated karyotyping that allows for accurate identification of the origin of chromosome bands and subtelomeres.
-
批准号:12470519
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.65万
-
财政年份:2000
-
负责人:KAKAZU Naoki
-
依托单位:
Development of new spectral karyotyping (SKY) techniques in cytogenetic analysis
-
批准号:11671010
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1999
-
负责人:KAKAZU Naoki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
miRNA-124-3p 靶向 PAX3/p53 通路调控肛门直肠畸形肠神经系统发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王佚
-
依托单位:
PAX3通过生肌调节因子调控椎旁肌异常发育在青少年特发性脊柱侧凸发病中的机制研究
-
批准号:82002260
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:秦晓东
-
依托单位:
苯并芘暴露经Dnmt1高甲基化Pax3基因致神经管畸形的机制研究
-
批准号:31900608
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:林珊珊
-
依托单位:
椎旁肌发育调控因子PAX3参与特发性脊柱侧凸发病的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:
-
依托单位:
PAX3相关信号通路介导人类毛囊神经嵴干细胞定向分化为成熟黑素细胞的作用和机制研究
-
批准号:81703145
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:陈淑君
-
依托单位:
脊髓发育过程中Pax3/Pax7参与调控神经细胞分化和轴突生长的分子机制研究
-
批准号:81771226
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2017
-
负责人:林俊堂
-
依托单位:
胚胎干性基因PAX3通过调控Wnt信号通路在神经胶质瘤细胞中发挥癌基因作用的分子机制
-
批准号:81502147
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:夏亮
-
依托单位:
PAX3/p53途径调控胶质瘤干细胞分化与凋亡的机制研究
-
批准号:81402447
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:朱慧
-
依托单位:
miR-27b介导Pax3基因调控山羊骨骼肌细胞增殖与分化研究
-
批准号:31301934
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2013
-
负责人:凌英会
-
依托单位:
Pax3/Pax7对猪肌纤维发育及类型转化的决定作用
-
批准号:31372323
-
项目类别:面上项目
-
资助金额:83.0万元
-
批准年份:2013
-
负责人:陈代文
-
依托单位: